|Endymed Ltd -- Israel Stock|| |
ILS 2.74 0.04 1.48%
Vice President - Business Development
Mr. Amir Schori will no longer serve as Vice President Business Development at Endymed Ltd. effective March 16, 2018. He held this role from April 27, 2014. Additionally, he will not hold this role at the Subsidiary, Endymed Medical. His work experience includes the following roles Sales and Business Development Manager at SodaStream Ltd. and Marketing Manager at SodaStream Ltd.
Age: 42 President Since 2014
972 4 630 9100 http://www.endymed.com
Schori holds a Bachelor of Business Administration degree from the Michlala Leminhal.
The company has return on total asset (ROA)
of (14.21) %
which means that it has lost $14.21 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE)
of (70.03) %
meaning that it generated substantial loss on money invested by shareholders.
Endymed Ltd., a medical technology company, designs, develops, and commercializes energy based aesthetic treatment systems for the professional markets. Endymed Ltd (ENDY) is traded on Tel Aviv Stock Exchange in Israel. It is located in Caesarea, and employs 10 people.